| Lastest Insider Transactions Of Axsome Therapeutics, Inc. ( AXSM ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | Chief Financial Officer | 2026-01-22 | Sell | 12,000 | 187.92 | 2,255,040 | 2026-01-23 19:00:04 |
| AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | Chief Financial Officer | 2026-01-22 | Option Exercise | 12,000 | 3.50 | 42,000 | 2026-01-23 19:00:04 |
| AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Officer | 2026-01-21 | Sell | 7,500 | 184.44 | 1,383,300 | 2026-01-23 19:00:03 |
| AXSM | Axsome Therapeutics, Inc. | Maizel Ari | Chief Commercial Officer | 2026-01-21 | Option Exercise | 7,500 | 70.73 | 530,475 | 2026-01-23 19:00:03 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2026-01-05 | Sell | 139,414 | 171.30 | 23,881,618 | 2026-01-07 19:00:20 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2026-01-05 | Option Exercise | 139,414 | 8.02 | 1,118,100 | 2026-01-07 19:00:20 |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Directior | 2025-12-31 | Sell | 37,577 | 165.18 | 6,206,969 | 2026-01-02 19:02:02 |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Directior | 2025-12-31 | Option Exercise | 37,577 | 5.46 | 205,135 | 2026-01-02 19:02:02 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-12-02 | Sell | 79,973 | 145.66 | 11,648,582 | 2025-12-04 19:39:43 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-12-02 | Option Exercise | 79,973 | 8.02 | 641,383 | 2025-12-04 19:39:43 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-11-03 | Sell | 163,939 | 133.07 | 21,815,670 | 2025-11-05 19:01:02 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-11-03 | Option Exercise | 163,939 | 8.02 | 1,314,791 | 2025-11-05 19:01:02 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-10-06 | Sell | 45,384 | 119.38 | 5,418,060 | 2025-10-08 21:08:08 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-10-06 | Option Exercise | 45,384 | 8.02 | 363,980 | 2025-10-08 21:08:08 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-09-22 | Sell | 10,000 | 115.96 | 1,159,600 | 2025-09-22 19:00:03 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-09-22 | Option Exercise | 10,000 | 2.85 | 28,500 | 2025-09-22 19:00:03 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-09-16 | Sell | 45,783 | 114.48 | 5,241,127 | 2025-09-17 19:00:04 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-09-16 | Option Exercise | 40,000 | 4.91 | 196,500 | 2025-09-17 19:00:04 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-09-16 | Sell | 45,783 | 114.48 | 5,241,127 | 2025-09-17 19:00:04 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-09-16 | Option Exercise | 40,000 | 4.91 | 196,500 | 2025-09-17 19:00:04 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-09-12 | Sell | 62,880 | 117.08 | 7,361,892 | 2025-09-16 19:36:45 |
| AXSM | Axsome Therapeutics, Inc. | TABUTEAU HERRIOT | Chief Executive Officer 10% Owner | 2025-09-12 | Option Exercise | 62,880 | 8.02 | 504,298 | 2025-09-16 19:36:45 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2025-09-08 | Buy | 1,575 | 127.28 | 200,466 | 2025-09-09 20:11:58 |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Directior | 2025-09-05 | Sell | 9,127 | 125.07 | 1,141,514 | 2025-09-05 19:43:07 |
| AXSM | Axsome Therapeutics, Inc. | Saad Mark E | Directior | 2025-09-05 | Option Exercise | 9,127 | 9.00 | 82,143 | 2025-09-05 19:43:07 |
| AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Directior | 2025-09-02 | Sell | 13,464 | 123.68 | 1,665,228 | 2025-09-02 19:11:34 |
| AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Directior | 2025-08-27 | Sell | 60,000 | 121.72 | 7,303,400 | 2025-08-29 19:08:22 |
| AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Directior | 2025-08-22 | Sell | 36,694 | 120.05 | 4,405,216 | 2025-08-26 19:00:03 |
| AXSM | Axsome Therapeutics, Inc. | Murdock Hunter R. | General Counsel | 2025-06-20 | Sell | 13,514 | 101.42 | 1,370,647 | 2025-06-23 19:42:47 |
| AXSM | Axsome Therapeutics, Inc. | Murdock Hunter R. | General Counsel | 2025-06-20 | Option Exercise | 13,514 | 29.91 | 404,204 | 2025-06-23 19:42:47 |
| AXSM | Axsome Therapeutics, Inc. | Murdock Hunter R. | General Counsel | 2025-06-16 | Sell | 22,500 | 101.19 | 2,276,850 | 2025-06-18 21:16:04 |
| AXSM | Axsome Therapeutics, Inc. | Murdock Hunter R. | General Counsel | 2025-06-16 | Option Exercise | 22,500 | 29.91 | 672,975 | 2025-06-18 21:16:04 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-06-09 | Sell | 25,000 | 110.44 | 2,761,000 | 2025-06-10 19:00:05 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-06-09 | Option Exercise | 25,000 | 8.02 | 200,500 | 2025-06-10 19:00:05 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2025-05-27 | Sell | 7,500 | 104.45 | 783,375 | 2025-05-29 19:00:05 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-05-27 | Sell | 40,673 | 104.07 | 4,232,636 | 2025-05-28 21:52:55 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2025-05-27 | Option Exercise | 40,673 | 6.47 | 263,154 | 2025-05-28 21:52:55 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2025-05-20 | Sell | 3,000 | 107.49 | 322,473 | 2025-05-20 21:46:49 |
| AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | Chief Financial Officer | 2025-02-13 | Sell | 15,000 | 130.10 | 1,951,530 | 2025-02-14 21:20:36 |
| AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | Chief Financial Officer | 2025-02-13 | Option Exercise | 15,000 | 3.50 | 52,500 | 2025-02-14 21:20:36 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2025-01-03 | Option Exercise | 9,127 | 9.00 | 82,143 | 2025-01-06 16:06:29 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2024-11-19 | Option Exercise | 33,410 | 5.94 | 198,455 | 2024-11-20 16:30:41 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2024-05-29 | Sell | 7,910 | 74.31 | 587,813 | 2024-05-29 20:12:56 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2024-05-29 | Option Exercise | 13,693 | 1.30 | 17,801 | 2024-05-29 20:12:56 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2024-05-28 | Sell | 10,497 | 75.17 | 789,107 | 2024-05-29 20:11:32 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2024-04-01 | Sell | 24,662 | 77.24 | 1,904,942 | 2024-04-01 18:46:51 |
| AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Chief Operating Officer | 2024-04-01 | Option Exercise | 24,662 | 1.30 | 32,061 | 2024-04-01 18:46:51 |
| AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Directior | 2024-03-14 | Sell | 32,323 | 69.84 | 2,257,449 | 2024-03-15 20:05:27 |
| AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | Directior | 2024-03-14 | Option Exercise | 32,323 | 24.44 | 789,986 | 2024-03-15 20:05:27 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2023-09-15 | Sell | 29,588 | 75.18 | 2,224,430 | 2023-09-15 18:30:32 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2023-09-15 | Option Exercise | 11,016 | 3.67 | 40,429 | 2023-09-15 18:30:32 |
| AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Directior | 2023-01-03 | Option Exercise | 17,501 | 1.30 | 22,751 | 2023-01-04 16:11:19 |
